7.68新台幣0.06(0.79%)
2022/07/01更新
績效 / 1月5.06%
3月7.91%
1年27.41%
晨星評等-
淨值走勢
基金總覽
基金規模1,028.76百萬截至 2022-05-31
持股明細 / 風險評估
- 1.美國77.04%
- 2.已開發亞洲6.17%
- 3.新興亞洲5.07%
- 4.歐元區0.03%
- 5.中東0.01%
- 1.健康護理81.72%
- 2.科技2.39%
- 3.基本物料2.29%
- 4.工業1.93%
- 1.Regeneron Pharmaceuticals Inc6.90%
- 2.UnitedHealth Group Inc6.18%
- 3.Lotus Pharmaceutical Co Ltd4.57%
- 4.Bristol-Myers Squibb Co4.48%
- 5.Pfizer Inc4.20%
- 1.美國77.04%
- 2.已開發亞洲6.17%
- 3.新興亞洲5.07%
- 4.歐元區0.03%
- 5.中東0.01%
- 1.Regeneron Pharmaceuticals Inc6.90%
- 2.UnitedHealth Group Inc6.18%
- 3.Lotus Pharmaceutical Co Ltd4.57%
- 4.Bristol-Myers Squibb Co4.48%
- 5.Pfizer Inc4.20%
- 1.健康護理81.72%
- 2.科技2.39%
- 3.基本物料2.29%
- 4.工業1.93%